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Perspective of Saudi undergraduate pharmacy students on pharmacovigilance and adverse drug 
reaction reporting: A National Survey 
ABSTRACT 
Objective: 7R HYDOXDWH 6DXGL XQGHUJUDGXDWH SKDUPDF\ VWXGHQWV¶ NQRZOHGJH DWWLWXGH DQG UHDGLQHVV
towards pharmacovigilance and reporting of adverse drug reactions (ADRs). 
Methods: A cross-sectional survey was conducted between January 15, 2016 and February 18, 2016 using 
a structured, validated and pilot-tested questionnaire among senior (year 4, 5 and 6) undergraduate 
pharmacy students enrolled at a governmental or private university/college. Students completed an online 
27-item questionnaire developed using Google FRUPV The questionnaire consisted of four sections: 
demographics; knowledge about pharmacovigilance and ADR reporting; attitudes towards ADR reporting; 
DQGSKDUPDF\VWXGHQWV¶UHDGLQHVVtowards ADR reporting.  
Results: Two hundred and fifty-nine students completed the questionnaire. Most of the participants were 
females (n = 174, 67.2%) and were year 4 (n = 128, 49.4%) students. Out of a total possible score of seven, 
the mean knowledge score (SD) was 4.15 (1.1). Multiple linear regression showed that after adjusting for 
gender and program of study (BPharm/PharmD), year of the study was found to be an independent 
predictor (P =0.03) of the total knowledge score. More than half of the respondents (n = 166, 64.1%) 
acknowledged that they do not know how to report ADRs to the relevant authorities in Saudi Arabia. The 
majority (n = 213, 82.2%) of respondents believed that information on how to report ADRs should be taught 
to senior pharmacy students.  
Conclusion: This study highlighted wide knowledge gaps about pharmacovigilance and ADR reporting 
among senior pharmacy students. There is a clear need to put more emphasis on theoretical and 
experiential aspects of ADR reporting in pharmacy curriculum.   
Keywords:  
Pharmacovigilance; Adverse drug reaction, Saudi Arabia; Pharmacy; Curriculum; Pharmacist 
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Specific Contribution to Literature: 
This study further builds on existing evidence highlighting the issue of deficiencies in pharmacy 
undergraduate curriculum pertaining to pharmacovigilance and ADR reporting, especially in countries 
where patient-centered pharmacist role has not yet fully evolved. This is the first study that has assessed 
SKDUPDF\ VWXGHQWV¶ NQRZOHGJH DWWLWXGHV DQG UHDGLQHVV WRZDUGV $'5 UHSRUWLQJ LQ 6DXGL $UDELD 2XU
findings can partly explain poor ADR reporting practices by pharmacists reported by previously conducted 
studies in Saudi Arabia. In addition, this study has tested the feasibility of using web-based social media 
applications in recruiting participants for academic research. We have shown that recruitment through social 
media is possible, efficient and economical. We hope that future researchers will use this approach for 
recruitment especially in instances where participants are widely distributed geographically.   
Introduction 
While medications are used globally to achieve desired therapeutic outcomes, they may also cause 
undesirable side effects.1 An adverse drug reaction (ADR) is defined by the World Health Organization 
(WHO)2 DV³$UHVSRQVHWRDGUXJZKLFKLVQR[LRXVDQGXQLQWHQGHGDQGZKLFKRFFXUVDWGRVHVQRUPDOO\
used in man for the prophylaxis, diagnosis, or therapy of disease, or for the modifications of physiological 
IXQFWLRQ´ ADRs are a common cause of morbidity and mortality in both hospital and community settings.1 
ADRs have been estimated to affect 2.2 million people worldwide and are responsible for a 100,000 deaths 
yearly.3 Furthermore, the economic burden associated with ADRs has been estimated at 136 billion United 
Sates Dollars annully.1,4-6 Studies have reported that 5- 20% of all hospital admissions are attributable to 
ADRs.5,7  
3KDUPDFRYLJLODQFH39LVGHILQHGDVWKH³VFLHQFHDQGDFWLYLWLHVUHODWLQJWRWKHGHWHFWLRQDVVHVVPHQW
understanding and prevention of adverse effects or any other drug-UHODWHGSUREOHP´8,9 Prompt reporting of 
suspected ADRs is fundamental in the post-marketing surveillance of medicines and is considered to be 
the mainstay of pharmacovigilance.2 A large proportion of ADRs can be prevented by improved drug 
prescribing, administration and through consistent and prompt recording and reporting.2 The present study 
will focus only on the prevention of adverse effects component of pharmacovigilance. 
Post marketing surveillance, initiated in the 1960s by the WHO after the µWKDOLGRPLGH¶ FULVLV LV
practiced by more than 70 countries worldwide for early detection and prevention of ADRs using the 
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spontaneous adverse drug reaction reporting system (SADRRS).1,10,11 In March 2009, the Saudi Food and 
Drug Authority (SFDA) established National Pharmacovigilance Center (NPC) and launched its national 
pharmacovigilance program in order to prevent and detect ADRs at an early stage.12  
Pharmacists, being drug experts, have a central role in ensuring safe and effective use of drugs by 
detecting and reporting ADRs.13-18 In Malaysia, more than half of the total ADR reports received by their 
National Pharmacovigilance Center were submitted by pharmacists.19 A number of studies conducted 
internationally as well as in Saudi Arabia have suggested a lack of awareness among both community and 
hospital pharmacists about ADR reporting systems and guidelines.20-24 Lack of emphasis and training on 
pharmacovigilance and ADR reporting during undergraduate pharmacy degree may contribute to the lack 
of awareness and negative attitudes towards ADR reporting among hospital and community pharmacists 
documented in earlier studies. As future pharmacy practitioners, pharmacy students need to be well 
educated and trained on how to document, distinguish and report ADRs. Proper assessment must be made 
to determine whether pharmacy graduates are well educated and trained to report ADRs.26 Internationally 
a number of studies have beHQ FRQGXFWHG WR HYDOXDWH SKDUPDF\ VWXGHQWV¶ DZDUHQHVV DERXW
pharmacovigilance and ADR reporting.25-28 However, no national study has been conducted in Saudi Arabia 
DVVHVVLQJSKDUPDF\VWXGHQWV¶NQRZOHGJHDWWLWXGHVDQGUHDGLQHVV WRZDUGV$'5UHSRUWLQJ7KHSresent 
study was designed to evaluate Saudi SKDUPDF\VWXGHQWV¶NQRZOHGJHDWWLWXGHDQGUHDGLQHVVWRZDUGVADR 
reporting. 
Methods 
A cross-sectional study was conducted in Saudi Arabia from January 15 to February 18, 2016 for a 
period of four weeks.  
Ethical approval 
The ethical approval was obtained from the ethics committee at the College of Pharmacy, Umm-Al-
Qura University. In addition, permission was also obtained from respective Facebook, Twitter and 
WhatsApp page administrators before publishing the survey link on a particular page. 
Questionnaire design 
The initial draft of the online questionnaire was developed based on the information obtained from an 
extensive literature search and review about ADR reporting among pharmacy students.25-28 Although Arabic 
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is the national language of Saudi Arabia, the questionnaire was developed in the English language as it is 
the official medium of instruction at all pharmacy schools across the Kingdom. The face and content validity 
of the questionnaire was undertaken by two experienced pharmacy academics (one Assistant Professor 
and one Professor) and two senior pharmacy students. The questionnaire was then piloted on a sample of 
10 pharmacy students. Based on VWXGHQWV¶ IHHGEDFNDQGGLVFXVVLRQZLWKH[SHUWV, three questions were 
dropped and the final version consisted of 27-items that were divided into four sections. The first section 
consisted of 5 items about student demographics, such as age, gender, academic year, pharmacy program, 
and current university. The second section (10 questions) ZDVGHVLJQHG WRDVVHVVSKDUPDF\VWXGHQWV¶
knowledge towards pharmacovigilance and ADR reporting. For each question in this section, students were 
asked to choose yes, no or dRQ¶WNQRZoptions. A score of 1 was given for each correct answer and 0 for 
each wrong answer. The maximum possible score was 7 and the minimum was 0 as only 7 out of 10 
questions were deemed suitable for scoring. The third section consisted of 5 items designed to evaluate 
the attitude of pharmacy students toward pharmacovigilance activities and ADR reporting. The questions 
were framed into a 5-point Likert-scale format (1 = strongly agree, 2 = agree, 3 = neutral, 4 = disagree, and 
5 = strongly disagree). In order to avoid affirmation or agreement bias, both positive and negative statement-
based items were included within each section. The fourth section included 7 items and was designed to 
evaluate SKDUPDF\ VWXGHQWV¶ UHDGLQHVV WRZDUGV ADR reporting and coverage of these topics in their 
respective curricula. Like the previous section, a five-SRLQW /LNHUW VFDOH ZDV XVHG WR HOLFLW VWXGHQWV¶
responses. The questionnaire was developed and distributed using Google Forms. 
Sampling and recruitment 
Pharmacy students were approached and recruited through social networking websites (Facebook, 
Twitter, and WhatsApp). Social networking websites were used for recruitment as they offer 
convenient, effective, economical, and fast method to recruit participants. The sampling frame consisted of 
all full-time senior undergraduate pharmacy (4, 5 and 6 year) students enrolled at a governmental or private 
university/college in Saudi Arabia in either BPharm or PharmD program. Both BPharm and PharmD are 
considered entry-level qualifications in Saudi Arabia. BPharm is typically a five year program and PharmD 
is a six year program. The final year of PharmD program involves clinical clerkship/training year for PharmD 
students. The questionnaire link was posted on 20 different social media pages which were identified 
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through an online search and using a snow balling technique (a type of non-probability sampling technique 
where existing subjects help researchers to identify new subjects).29 The survey links were posted on 
FROOHJHV¶official social media pages. If official social media pages could not be retrieved the links were 
posted on unofficial (run by student groups) social media pages. An invitation letter outlining the aims of 
the study was attached to the questionnaire. All information collected from this study was kept confidential. 
Consent for participation was implied by completion and submission of the survey. The survey link was 
reposted every week for four weeks during the study period on each of the social media pages.  
Statistical analysis 
Data were analyzed using SPSS version 18. Descriptive statistics, frequencies and percentages were 
used to summarize data. Since data were not normally distributed, the Mann-Whitney test or the Kruskal-
Wallis test were used as appropriate, to compare total knowledge score across various respondent 
demographics. The Chi-VTXDUHWHVWZDVXVHGWRDVVHVVDVVRFLDWLRQEHWZHHQUHVSRQGHQWV¶DWWLWXGHVDQG
demographic characteristics. Fisher¶V Exact test was used instead of the Chi-square test if 20% or more of 
the cells in the table had expected frequencies of less than 5. Multiple linear regression analysis was used 
to determine the predictors of good knowledge score. P < 0.05 was considered statistically significant. 
Results 
A total of 259 students completed the study. The mean (SD) age of the students was 22 (1.6) years. 
Most of the students (n = 174, 67.2%) were female and year 4 students (n = 128, 49.4%). The vast majority 
(n = 217, 83.8%) of the students could not identify the correct definition of pharmacovigilance. However, 
more than two thirds (n = 179, 69.1%) of the students correctly identified the definition of an ADR. Only 
59.1% of the students were aware that SFDA is the national organization responsible for collecting ADRs 
in Saudi Arabia. More than two thirds (81.5%) of the students incorrectly stated that it is necessary to 
establish the association between an ADR and suspected drug before reporting it (Table 1).  
The total mean (SD) knowledge score for pharmacovigilance and ADR reporting was 4.15 (1.14). A 
statistically significant difference was found in the total mean knowledge score across year of study with 
year 6 students achieving a higher knowledge score compared to year 4 and 5 students (P = 0.02). 
However, there was no significant difference in the total mean knowledge score by gender (male vs female) 
(P = 0.38) and program of study (BPharm vs PharmD) (P = 0.79) (Table 2). Multiple regression analysis 
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found that after adjusting for gender and program of study (BPharm/PharmD), year of the study was found 
to be an independent predictor (P =0.03) of total knowledge score. 
More than two-thirds (n = 166, 64.1%) of the students either agreed or strongly agreed that they do 
not know how to report ADRs to the relevant authorities in Saudi Arabia. Consequently, the majority (n = 
213, 82.2%) of the students either agreed or strongly agreed that information on how to report ADRs should 
be taught to senior pharmacy students (Table 3). Over two-thirds (n = 205, 79.1%) of the students either 
agreed or strongly agreed that the pharmacovigilance concept should be included as a core topic in 
pharmacy curriculum. Only one third of the students (33.9%) agreed or strongly agreed that they had 
received training on ADR reporting during their clinical clerkship. Less than half (44.4%) of the students 
stated that they are capable of reporting ADRs (Table 3). 
The majority (87.3%) of the students believed that pharmacists are one of the most important 
healthcare professionals for reporting ADRs and 69.4% agreed or strongly agreed that ADR reporting 
should be made compulsory for pharmacists. Almost 80% of the students (n = 207) expressed willingness 
to report ADRs in future practice (Table 4).  
Discussion 
To the best of our knowledge, this is the first cross-sectional study that evaluated knowledge and 
attitude of undergraduate pharmacy students towards reporting of ADRs in Saudi Arabia. Our study builds 
on previous international studies highlighting the need to strengthen knowledge and skills related to ADR 
detection and reporting in pharmacy curriculum.25-28 It highlights wide knowledge gaps about 
pharmacovigilance and ADR reporting among senior pharmacy students in Saudi Arabia. This calls for a 
thorough review of national pharmacy curriculum involving all stakeholders with an aim to improve 
knowledge and skills required to detect and report ADRs.   
More than two-thirds of the students stated that they were unaware of the methods to report ADRs to 
relevant authorities in Saudi Arabia. These results indicate that, irrespective of the study program (BPharm 
or PharmD) and the university offering such programs, students seem to lack awareness about 
pharmacovigilance and reporting of ADRs. It was further evident by the fact that majority (73.7%) of the 
students confirmed they had never seen the official ADR reporting form. Similar findings have also been 
reported previously involving pharmacy students in Malaysia.25-26 Well designed educational training 
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programs and workshops on pharmacovigilance may clarify and enhance the knowledge of both students 
and healthcare professionals about the requirements of ADR reporting.25,28,30  
There were also some misconceptions on the type of ADRs that are required to be reported. The 
majority of students mistakenly believed that establishing association between ADR and the suspected 
drug is compulsory before reporting it. Additionally, more than two-thirds (86.1%) of the students believed 
that ADRs associated with herbal products should not be reported. These findings are consistent with those 
of similar reports about healthcare professionals.26,32,33  
The majority (87.3%) of the students agreed or strongly agreed that the pharmacist is one of the most 
important healthcare professionals who report ADRs. These findings are consistent with the findings of 
other studies for healthcare professionals.27,35 Importantly, majority (79.9%) of the students considered 
reporting ADRs as their moral obligation and expressed a positive attitude toward pharmacovigilance and 
the importance of reporting ADRs. Furthermore, there was a major consensus (79.1%) among the students 
that pharmacovigilance should be included as a core topic in the curriculum of pharmacy. These results 
reinforce the results of previous studies conducted internationally (outside Saudi Arabia) involving 
pharmacy students. 26-28 
The present study results emphasize the importance of providing explicit education and training on 
reporting ADRs to pharmacists at both undergraduate and professional levels. Previous studies aimed at 
investigating the extent of pharmacovigilance education provided to medical and pharmacy students 
suggested need for more time to be spent on pharmacovigilance education.35 Research indicates that 
training is associated with an increased likelihood to ADR reporting.36,37 A recent study in Denmark 
demonstrated positive impact of a community pharmacy internship program on improving clinical 
competencies of pharmacy students to identify and report ADRs.38 Furthermore, pharmacists who receive 
specific educational training on ADR reporting are more likely to report ADRs.39 
Limitations 
There are some limitations to the findings of the present study. First, questionnaire based studies are 
subject to recall bias. Second, the low survey response rate from the students was unexpected. Although 
the authors are not aware of the total number of pharmacy students enrolled in governmental and private 
institutes, it can be safely assumed that the response rate was quite low. However, all efforts were made 
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to maximize the response rate such as the inclusion of all universities/colleges offering pharmacy program 
in the study and the use of 20 different social media pages to post the online questionnaire. Finally, the 
reliability of using social media applications for research purposes is not known. It is possible that some 
students might have responded more than once and/or sought external help in completing the 
questionnaire. Future research in this topic should explore the views of recent pharmacy graduates as well 
with the aim of identifying not only curriculum needs and gaps but also instruction methods to teach 
pharmacovigilance topic.  
Conclusion 
The results of this national study highlight wide knowledge gaps among senior pharmacy students 
with regards to pharmacovigilance and ADR reporting in Saudi Arabia. The students perceived a clear need 
to review the current pharmacy curriculum with more emphasis should be laid on both theoretical and 
experiential aspects of ADR reporting. All graduating pharmacists should be able to identify and report 
ADRs in their future clinical practice, thus optimizing patient safety.   
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College of Pharmacy, Umm-Al-Qura University, Saudi Arabia and Ms. Lama Hamad Basalilah for their help 
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